• Blog
  • Biological Indicators Market Report

    Biological Indicators Market Report

    Biological Indicators Market Report
    Report code - SRHL310 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global Biological Indicators Market, Trends, Dynamics, and Market Analysis
    See more...

    Impact of COVID-19 on Biological Indicators Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on Biological Indicators Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The Global Biological Indicators Market is projected to grow from USD 345.2 million in 2020 to USD 480.7 million by 2026 at a CAGR of over 5.7% during the forecast period.

    Figure: Global Biological Indicators Market Size, 2020-2026 (USD Million)

    Wish to get a free sample? Register Here

    What are Biological Indicators?

    Biological Indicators are as defined by ISO and ANSI/AAMI are test systems containing viable microorganisms offering a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, offering a level of confidence in the process.

    Key Players

    Key players operating in the global biological indicators market are-

    • 3M (The U.S),
    • Getinge Group (Sweden),
    • Cantel Medical (The U.S),
    • Mesa Laboratories (The U.S),
    • Steris (The U.S),
    • Fuze Medical (The U.S),
    • Matachana (Spain),
    • Hu-Friedy (The U.S),
    • Advanced Sterilization (The U.S), and
    • Bag Health Care (Germany).

    Market Dynamics

    Biological indicators exhibit reliable results when compared to chemical indicators, thus drives the product preference.

    • It is considered as a gold standard for the assessment of sterilization. Rise in R&D activities coupled with strict government regulations are the key factors expected to propel the product demand.
    • In addition, growing demand for medical devices and medicines owing to the high prevalence of chronic diseases such as diabetes, asthma, cancer, and arthritis are likely to augment the market growth.

    Segment Analysis

    End Use Trends

    By end-use, the biological indicators market has been segmented into hospitals, pharmaceutical companies, and others. Under these, the hospital segment held a substantial market share in 2020 and is likely to register the fastest CAGR in the following years. This is mainly attributed to growing sterilization procedures that are repeatedly carried out in hospitals. Moreover, stringent regulatory guidelines for sterilization of biologics, medical devices, and drugs are propelling the biological indicators market.

    Regional Trends

    By region, the market in the North America garnered a significant market share in 2020 and is projected to grow at a steady CAGR during the assessment period.

    This is mainly attributed to advanced healthcare infrastructure, increasing awareness among population, growing favourable government initiatives and increasing prevalence of diseases due to a change in lifestyle, which further augments the regional growth.

    COVID-19 Impact on Global Biological Indicators Market

    The ongoing COVID-19 pandemic has positively influenced the biological indicators industry due to the increasing surge of coronavirus cases across the globe. The rising epidemiological numbers around the world create a surging need for biological indicators, thus boosting the product demand.

    Critical Questions Answered in the Report

    • What are the key trends in the global biological indicators market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global biological indicators market?
    • What are the key strategies adopted by the major vendors to lead in the global biological indicators market?
    • What is the market share of the top vendors?

    Wish to know more about the study? Get a customised report here.

    Target Audience

    • Biological indicators companies
    • Biological indicators vendors
    • R&D centers
    • Laboratory clinics
    • Hospitals

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The biological indicators market is expected to witness an impressive growth of 5.7% CAGR in the foreseeable future.

    3M (The U.S), Getinge Group (Sweden), Cantel Medical (The U.S), Mesa Laboratories (The U.S), Steris (The U.S), Fuze Medical (The U.S), Matachana (Spain), Hu-Friedy (The U.S), Advanced Sterilization (The U.S) and Bag Health Care (Germany) are among the key players in the biological indicators market.

    The biological indicators market is expected to reach USD 480.7 million in the coming years.

    Rise in R&D activities coupled with strict government regulations, growing demand for medical devices and medicines owing to the high prevalence of chronic diseases are the factors driving the growth of biological indicators market.

    The hospital segment is expected to register the fastest CAGR in the biological indicators market in the following years.

    Biological indicators companies, Biological indicators vendors, R&D centers, Laboratory clinics, Hospitals are the target audience in the biological indicators market

    •